Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001140361-23-028161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-05-31 | ATRA | SEIDENBERG BETH C | Dir | A - Grant | $0.00 | +57.0K | 115.7K | +97% | $0 |
| D | 2023-06-02 | 2023-05-31 | ATRA | SEIDENBERG BETH C | Dir | A - Grant | $0.00 | +79.5K | 79.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-31 | A | A | 57,000 | $0.00 | 115,689 | D | — | — | (F1) These restricted stock units shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-05-31 | A | A | 79,500 | $0.00 | 79,500 | D | $1.53 · — to 2033-05-30 | 79,500 Common Stock | (F2) The option shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service. |